RB
Therapeutic Areas
Ony Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Infasurf® (calfactant) | Prevention & Treatment of Respiratory Distress Syndrome (RDS) in newborns | Approved |
| InfasurfAero™ | Non-Invasive Surfactant Delivery for RDS in Preterm Newborns | Phase 2/3 |
| AerVia® Neonatal Supraglottic Airway | Neonatal Airway Management | Commercial |
| Acellular Tissue Engineered Vessels (ATEV) | Neonatal vascular access/repair (assumed) | Pre-clinical |